Gender bias in research: How does it affect evidence based medicine?

Journal of the Royal Society of Medicine

Volumn 100, Issue 1, 2007, Pages 2-3

  Holdcroft, Anita ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

CLINICAL TRIAL; EDITORIAL; EVIDENCE BASED MEDICINE; GENDER BIAS; HIGH RISK POPULATION; HUMAN; MEDICAL PRACTICE; MEDICAL RESEARCH; MORBIDITY; MORTALITY; PATIENT SAFETY; PRACTICE GUIDELINE; PRENATAL EXPOSURE; SEX DIFFERENCE; SOCIOECONOMICS; UNITED KINGDOM; UNITED STATES;

BIOMEDICAL RESEARCH; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; PREJUDICE;

EID: 33847763713     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.100.1.2     Document Type: Editorial

References (15)

1. Weisz D, Gusmano MK, Rodwin VG. Gender and the treatment of heart disease in older persons in the United States, France, and England: a comparative, population-based view of a clinical phenomenon. Gend Med. 2004;1:29-40
2. Soderstrom M. Why researchers excluded women from their trial populations. Lakartidningen 2001;98:1524-8
3. Rochon PA, Clark JP, Binns MA, Patel V, Gurwitz JH. Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction. CMAJ 1998;159:321-7
4. NIH Guidelines on the inclusion of women and minorities as subjects in clinical research (1994) 59 Fed. Reg. 14508-14513
5. Light KP, Lovell AT, Butt H, Fauvel NJ, Holdcroft A. Adverse effects of neuromuscular blocking agents based on yellow card reporting in the UK: age and gender differences. Pharmacoepidemiol Drug Saf 2006;15:151-60
6. Simon V. Wanted: women in clinical trials. Science 2005;308:1517
7. Harris DJ, Douglas PS. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med 2000;343:475-80
8. Marshall E. From dearth to deluge. Science 2005;308:1569- 1572
9. Becker JB et al. Strategies and methods for research on sex differences in brain and behaviour. Endocrinology 2005;146:1650-73
10. Cain J, Lowell J, Thorndyke L, Localio AR. Contraceptive requirements for clinical research. Obstet Gynecol 2000;95:861-6
11. Anthony M, Berg MJ. Biologic and molecular mechanisms for sex differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics: part II. J Health Gend Based Med 2002;11:617-29
12. Brown BA, Long HL, Weitz TA, Milliken N. Challenges of recruitment: focus groups with research study recruiters. Women & Health 2000;31:153-66
13. Raine R, Goldfrad C, Rowan K, Black N. Influence of patient gender on admission to intensive care. J Epidemiol Community Health 2002;56:418 23
14. Doyle L, Payne S, Cameron A. Promoting gender equality in health. Equal Opportunities Commission 2003. http://www.eoc.org.uk/PDF/promoting gender equality in health.pdf (accessed 05/03/2006)
15. Bartlett C, Doyal I, Ebrahim S, et al. The causes and effects of sociodemographic exclusions from clinical trials. Health Technology Assessment 2005;9:Number 38